Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure

NCT06427304 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 637

Last updated 2026-04-20

No results posted yet for this study

Summary

Tne aim purpose of this observational, multicentre and propective study is to determine the prevalence of cardiac amyloidosis in geriatric patients aged 80 years and older hospitalized within the last 12 months for heart failure with left ventricular hypertrophy (septum ≥ 12 mm) on echocardiography

Conditions

  • Cardiac Amyloidosis

Sponsors & Collaborators

  • Gérond'if

    lead OTHER

Principal Investigators

  • Olivier Hanon, MD PhD · Geriatric Department, Broca hospital

Eligibility

Min Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2027-07-02
Completion
2028-02-02

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06427304 on ClinicalTrials.gov